Since EGFR and Src signaling pathways contribute to STAT3 activation in breast cancers [15], [34], we evaluated Necdin expression levels in human breast cancer cell lines with different levels of endogenous STAT3 activity. This evidence concerns the gene STAT3 and breast carcinoma.